*Opinion*

**Luis** 

**Uta** 

**Ingrid**

**Enrica**

#### **European Network on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (EUROMENE): Expert Consensus on the Diagnosis, Service Provision, and Care of People with ME/CFS in Europe**

**Nacul 1,2,\*,†, François Jérôme Authier 3,†, Carmen Scheibenbogen 4, Lorenzo Lorusso 5, Bergliot Helland 6, Jose Alegre Martin 7, Carmen Adella Sirbu 8, Anne Marit Mengshoel 9, Olli Polo 10, Behrends 11, Henrik Nielsen 12, Patricia Grabowski 13, Slobodan Sekulic 14, Nuno Sepulveda 15, Fernando Estévez-López 16, Pawel Zalewski 17, Derek F. H. Pheby 18, Jesus Castro-Marrero 19, Giorgos K. Sakkas Capelli 21, Ivan Brundsdlund 22, John Cullinan 23, Angelika Krumina 24, Jonas Bergquist 25,26, Modra Murovska 27, Ruud C. W. Vermuelen 28,‡ and Eliana M. Lacerda 29,‡**

	- 25 Department of Chemistry—Biomedical Center, Analytical Chemistry and Neuro Chemistry, Uppsala University, 751 23 Uppsala, Sweden; jonas.bergquist@kemi.uu.se

**Citation:** Nacul, L.; Authier, F.J.; Scheibenbogen, C.; Lorusso, L.; Helland, I.B.; Martin, J.A.; Sirbu, C.A.; Mengshoel, A.M.; Polo, O.; Behrends, U.; et al. European Network on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (EUROMENE): Expert Consensus on the Diagnosis, Service Provision, and Care of People with ME/CFS in Europe. *Medicina* **2021**, *57*, 510. https://doi.org/10.3390/ medicina57050510

1

 Academic Editor: Tibor Hortobágy<sup>i</sup>

Received: 11 April 2021 Accepted: 13 May 2021 Published: 19 May 2021

**Publisher's Note:** MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

**Copyright:** © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/).

 **20,**


**Abstract:** Designed by a group of ME/CFS researchers and health professionals, the European Network on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (EUROMENE) has received funding from the European Cooperation in Science and Technology (COST)—COST action 15111— from 2016 to 2020. The main goal of the Cost Action was to assess the existing knowledge and experience on health care delivery for people with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) in European countries, and to enhance coordinated research and health care provision in this field. We report our findings and make recommendations for clinical diagnosis, health services and care for people with ME/CFS in Europe, as prepared by the group of clinicians and researchers from 22 countries and 55 European health professionals and researchers, who have been informed by people with ME/CFS.

**Keywords:** Myalgic Encephalomyelitis/Chronic Fatigue Syndrome; diagnosis; health services; care
